Loading...

LXRX LEXICON PHARMACEUTICALS INC Capital Structure Changes 8-K Filing

LXCN

LXRX

LEXICON PHARMACEUTICALS INC

(LXRX)

2024 8-K

Show Summary

Show Summary

Equity Offerings

Financial Statements

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Filing with Quantitative Data

Filing with Quantitative Data

Filing with Quantitative Data

Capital Structure Change

Private Placement

Contract Renewal

Quantitative Data

External Links:

Lexicon Pharmaceuticals, Inc. filed a Certificate of Designations for the issuance of Series A Convertible Preferred Stock, which will automatically convert into 50 shares of Common Stock upon certain conditions being met.

AI Assistant

LEXICON PHARMACEUTICALS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.